Patents have nothing to do with Mayne.
Mithra own patents 100%.
Mayne are being absolutely shafted here.
They have paid 5-10 as much for US rights
as European countries combined with half
the population. Someone please explain
that one to me????
- Forums
- ASX - By Stock
- MYX
- Ann: NEXTSTELLIS FDA exclusivity & phase III data published
MYX
mayne pharma group limited
Add to My Watchlist
2.39%
!
$5.14

Ann: NEXTSTELLIS FDA exclusivity & phase III data published, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.14 |
Change
0.120(2.39%) |
Mkt cap ! $413.5M |
Open | High | Low | Value | Volume |
$5.00 | $5.14 | $4.94 | $611.5K | 121.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 1434 | $5.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.14 | 3513 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1023 | 5.120 |
9 | 2230 | 5.110 |
5 | 4727 | 5.100 |
5 | 1317 | 5.090 |
3 | 969 | 5.080 |
Price($) | Vol. | No. |
---|---|---|
5.140 | 1874 | 4 |
5.150 | 10676 | 3 |
5.160 | 3640 | 4 |
5.170 | 721 | 2 |
5.180 | 646 | 2 |
Last trade - 15.35pm 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online